Charles Ryhee
Stock Analyst at TD Cowen
(0)
# 4519
Out of 5,240 analysts
33
Total ratings
42.11%
Success rate
-14.66%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CVS Health | Maintains: Strong Buy | 73 80 | 51.66 | 54.86% | 5 | Nov 25, 2024 | |
Walgreens Boots Alli... | Maintains: Buy | 16 14 | 12.16 | 15.13% | 6 | Oct 22, 2024 | |
McKesson | Maintains: Strong Buy | 563 652 | 589.35 | 10.63% | 4 | May 8, 2024 | |
Chevron | Maintains: Outperform | 185 170 | 157.3 | 8.07% | 3 | Feb 24, 2023 | |
Evolent Health | Maintains: Outperform | 57 59 | 11.21 | 426.32% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 34 25 | n/a | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 170 169 | n/a | n/a | 2 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 59 72 | 124.07 | -41.97% | 1 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3150 810 | 1.73 | 46720.81% | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 240 188 | 9.43 | 1893.64% | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 360 395 | n/a | n/a | 4 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 29 | 14.79 | 96.08% | 1 | Mar 29, 2021 |